Influenza B Virus Victoria 504/00
#
-
Catalog numberMBS142734
-
Price:
-
Size5x0.05 mg
-
-
Products_typeNative Protein
-
Products_short_name[Influenza B Virus Victoria 504/00]
-
Products_name_syn[Influenza-B Victoria; Influenza-B Virus Victoria/504/00; Victoria 504/00]
-
PurityGreater than 90.0% as determined by SDS-PAGE.
-
FormThe B/ Victoria /53/99solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.Sterile Filtered colorless solution.
-
Storage_stabilityB/Victoria/504/00 although stable 4 degree C for 4 weeks, should be stored desiccated below -18 degree C. Please prevent freeze-thaw cycles.
-
Tested_applicationELISA (EIA)
-
DescriptionInfluenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.
-
Gene target
-
Short nameInfluenza B Virus Victoria 504/00
-
SpeciesVirus, Influenza, Viruses
-
Alternative nameInfluenza B Virus Victoria 504/00
-
Virusinfluenza
-
MeSH Data
-
Name
-
ConceptScope note: Radioimmunoassay of proteins using antibody coupled to an immunosorbent.
-
Tree numbers
- E05.478.566.380.830
- E05.478.566.639.830
- E05.601.470.380.830
- E05.601.470.639.830
-
Qualifiersethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data